Investing Profile

Rob Hopfner

InvestorVC
Managing Partner at Pivotal bioVenture Partners
pivotalbiovp.com/team-members...San Francisco, California
Photo of Rob Hopfner, Managing Partner at Pivotal bioVenture Partners
Your Intro Paths to Rob Hopfner

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Rob Hopfner on

cb
Current Investing Position
Pivotal bioVenture Partners Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
14
Current Fund Size
$300M

Rob Hopfner is on these Sector & Stage Rankings

Rob Hopfner's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Evommune
Series COct 2024$120M
Series BApr 2023$50M
Series ASep 2021$83M
SeedNov 2020$13M
$260M
Co-investors: Derek DiRocco (RA Capital), Ash Khanna (Pivotal bioVenture Partners), Mark Chin (Arix Bioscience)
Oculis
Post Ipo EquityMar 2023$91M
Series CMay 2021$57M
Series BJan 2018$21M
$190M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Zhi Yang (BVCF (Bioveda China Fund)), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital)
Plexium
Series BFeb 2022$100M
Series AJan 2021$35M
$140M
Co-investors: Kiersten Stead (DCVC (Data Collective)), Adam Goulburn (Dimension Capital), Tim Kutzkey (The Column Group)
Rallybio
Series BApr 2020$150M
$180M
Co-investors: Tim Shannon (Canaan Partners)
Inozyme
Series AApr 2019$67M
$67M
Co-investors: Sarah Bhagat (Sofinnova Investments)
Civitas Therapeutics
Series CAug 2014$55M
Series BSep 2013$38M
$110M
Co-investors: Tim Shannon (Canaan Partners)
Hyperion Therapeutics
Series CJun 2009$60M
$100M
Co-investors: James Healy (Sofinnova Investments), Jake Nunn (SR One Capital Management)